Abiopharma

🔍 Dalton Angela (Director)

Company: FORUM MARKETS Inc (FRMM)

Report Date: 2026-04-02

Detailed Transactions and Holdings:

• Acquired 203,562 shares of Common Stock (Direct)
  Date: 2026-04-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 203,562.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Consists of (i) 3,562 shares of Common Stock underlying restricted stock units ("RSUs") that will vest in full on the date of the Company's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service through such date, and (ii) 200,000 shares of Common Stock underlying RSUs, half of which will vest on the date of the Company's 2026 Annual Meeting of Stockholders and the other half of which will vest on the first anniversary of the grant date, subject to the Reporting Person's continued service through each such date.